11/19
03:02 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/14
08:15 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Medium
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
11/14
02:31 am
drrx
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... [Yahoo! Finance]
Low
Report
Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ... [Yahoo! Finance]
11/13
04:01 pm
drrx
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
11/12
05:37 pm
drrx
DURECT Q3 2024 Earnings Preview Nov. 12, 2024 5:35 PM ET By: Khushi Singh , SA News Editor [Seeking Alpha]
High
Report
DURECT Q3 2024 Earnings Preview Nov. 12, 2024 5:35 PM ET By: Khushi Singh , SA News Editor [Seeking Alpha]
11/11
02:05 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
11/6
04:54 pm
drrx
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update [Yahoo! Finance]
Low
Report
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update [Yahoo! Finance]
11/6
04:45 pm
drrx
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
Low
Report
DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update
11/3
02:07 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/26
02:10 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/18
02:06 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/17
08:30 am
drrx
DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
Low
Report
DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024
10/10
02:03 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/2
02:03 am
drrx
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
DURECT Co. (NASDAQ: DRRX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/26
08:17 am
drrx
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Low
Report
DURECT Co. (NASDAQ: DRRX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
9/25
08:00 am
drrx
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
Low
Report
DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis
9/4
04:30 pm
drrx
DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
Low
Report
DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference